Literature DB >> 20531291

Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling.

Mi-Ran Ki1, Moon-Jung Goo, Jin-Kyu Park, Il-Hwa Hong, Ae-Ri Ji, Seon-Young Han, Sang-Young You, Eun-Mi Lee, Ah-Young Kim, Sang-Joon Park, Hyun-Joo Lee, Shin-Yoon Kim, Kyu-Shik Jeong.   

Abstract

Our earlier report has shown that Helicobacter pylori promoted hepatic fibrosis in a murine model. Herein, in order to elucidate the mechanism by which H. pylori accelerate liver fibrosis, the authors investigated the changes in expression levels of mitogen-activated protein kinases (MAPKs), p53-related proteins, antioxidants, and proinflammatory cytokines in liver samples. H. pylori infection enhanced CCl4-induced MAP kinase activation and p53 signaling pathway as well as Bax- and proliferating-cell nuclear antigen expressions, whereas H. pylori alone induced neither of these expressions nor hepatic fibrosis. Moreover, mRNA expressions of inflammatory cytokines, glutathione peroxidase expression, and the proliferative index were strongly augmented in livers of the H. pylori with CCl4 treatment group compared with those of the CCl4-alone treatment group, whereas there was no difference in apoptotic index between the two groups. Interestingly, H. pylori treatment increased the number of α-fetoprotein-expressing hepatocytes independently of CCl4 intoxication. In vitro analyses, using an immortalized rat hepatic stellate cell (HSC) line, revealed that H. pylori lysates increased the proliferation of HSCs, which was boosted by the addition of transforming growth factor-beta1 (TGF-β1). Furthermore, the treatment of H. pylori lysates promoted the translocation of nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) into the nucleus based on an increase in the degradation of NF-κB inhibitor alpha, in the presence of TGF-β1, as did H2O2 treatment. In conclusion, H. pylori infection along with an elevated TGF-β1 may accelerate hepatic fibrosis through increased TGF-β1-induced pro-inflammatory signaling pathways in HSCs. Moreover, H. pylori infection might increase the risk of TGF-β1-mediated tumorigenesis by disturbing the balance between apoptosis and proliferation of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531291     DOI: 10.1038/labinvest.2010.109

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions.

Authors:  Yuehua Gong; Wang Wei; Liu Jingwei; Dong Nannan; Yuan Yuan
Journal:  Dig Dis Sci       Date:  2015-01-20       Impact factor: 3.199

Review 2.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

3.  Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Keyvan Heydari; Mohammad Yousefi; Reza Alizadeh-Navaei; Parisa Lotfi; Fateme Sheydaee; Maedeh Raei; Alireza Vahdatinia; Amirhossein Hessami; Sajjad Rafati; Mahmood Moosazadeh; Roya Ghasemian; Fatemeh Salehi; Haleh Massoudi; Fatemeh Ghaffari-Saravi; Sahar Rismantab
Journal:  Turk J Gastroenterol       Date:  2022-03       Impact factor: 1.555

Review 4.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 5.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

6.  Helicobacter pylori infection does not promote hepatocellular cancer in a transgenic mouse model of hepatitis C virus pathogenesis.

Authors:  Alexis García; Yan Feng; Nicola M A Parry; Amanda McCabe; Melissa W Mobley; Kvin Lertpiriyapong; Mark T Whary; James G Fox
Journal:  Gut Microbes       Date:  2013-08-07

Review 7.  Helicobacter pylori and extragastric diseases: A review.

Authors:  Antonietta Gerarda Gravina; Rocco Maurizio Zagari; Cristiana De Musis; Lorenzo Romano; Carmelina Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2018-08-07       Impact factor: 5.742

8.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

9.  The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia.

Authors:  Hassan Salehi; Mohammad Minakari; Arezoo Yaghoutkar; Elham Tabesh; Marziyeh Salehi; Leila Mirbagher
Journal:  Adv Biomed Res       Date:  2014-05-28

Review 10.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.